Febrile urinary tract infection in men

International Journal of Antimicrobial Agents

Volumn 22, Issue SUPPL. 2, 2003, Pages 89-93

  Ulleryd, Peter ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

E. coli virulence; Fever; Male; Prostate; PSA; Treatment; Urinary tract infection; Urography

Indexed keywords

BETA LACTAM ANTIBIOTIC; CIPROFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TRIMETHOPRIM; VIRULENCE FACTOR;

ACUTE PYELONEPHRITIS; ARTICLE; BACTERIAL STRAIN; BACTERIURIA; CLINICAL FEATURE; CLINICAL TRIAL; CYSTITIS; DIAGNOSTIC PROCEDURE; DISEASE PREDISPOSITION; ESCHERICHIA COLI; FEVER; GRAM NEGATIVE AEROBIC RODS AND COCCI; GRAM POSITIVE ASPOROGENOUS ROD-SHAPED BACTERIA; HUMAN; INTERMETHOD COMPARISON; INTRAVENOUS UROGRAPHY; MALE; MICROBIAL ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROSTATE; PROSTATITIS; RADIODIAGNOSIS; RECURRENT DISEASE; SEX DIFFERENCE; SYMPTOM; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT OUTCOME; URINARY TRACT DISEASE; URINARY TRACT INFECTION; UROLOGIC EXAMINATION;

EID: 0141869948     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(03)00228-0     Document Type: Article

References (56)

1. Winberg J., Andersen H.J., Bergström T., Jacobsson B., Larson H., Lincoln K. Epidemiology of symptomatic urinary tract infection in childhood. Acta Paediatr. Scand. 252:(Suppl):1974;1-20.
2. Wettergren B., Jodal U., Jonasson G. Epidemiology of bacteriuria during the first year of life. Acta Paediatr. Scand. 74:1985;925-933.
3. Kunin C.M. Urinary tract infections: detection, prevention, and management. 1997;Williams & Wilkins, Baltimore.
4. Vorland L.H., Carlson K., Aalen O. An epidemiological survey of urinary tract infections among outpatients in Northern Norway. Scand. J. Infect. Dis. 17:1985;277-283.
5. Norrby S.R. Short-term treatment of uncomplicated lower urinary tract infections in women. Rev. Infect. Dis. 12:1990;458-467.
6. Warren J.W., Abrutyn E., Hebel J.R., Johnson J.R., Schaeffer A.J., Stamm W.E. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin. Infect. Dis. 29:1999;745-758.
7. Lipsky B.A. Urinary tract infections in men. Epidemiology, pathophysiology, diagnosis and treatment. Ann. Intern. Med. 110:1989;138-150.
8. Hooton T.M., Stamm W.E. Management of acute uncomplicated urinary tract infection in adults. Med. Clin. N. Am. 75:1991;339-357.
9. Stamm W.E., Norrby S.R. Urinary tract infections: disease panorama and challenges. J. Infect. Dis. 183:(Suppl 1):2001;1-4.
10. Bauer H.W. Epidemiologie. Hofstetter A. Urogenitale infektionen. 1999;1-19 Springer, Berlin-Heidelberg.
11. Naber K.G., Bauernfeind A., Dietlein G., Wittenberger R. Urinary pathogens and bacterial sensitivity in hospitalized urological patients based upon clinical aspects. Scand. J. Urol. Nephrol. 104:(Suppl):1987;47-57.
12. Kawada Y. Comparison of complicated urinary tract infections in men and women. Infection. 22:(Suppl 1):1994;55-57.
13. Krieger J.N., Ross S.O., Simonsen J.M. Urinary tract infections in healthy university men. J. Urol. 149:1993;1046-1048.
14. Ulleryd P., Zackrisson B., Aus G., Bergdahl S., Hugosson J., Sandberg T. Selective urological evaluation in men with febrile urinary tract infection. BJU Int. 88:2001;15-20.
15. Svanborg Edén C., Hansson S., Jodal U., et al. Host-parasite interaction in the urinary tract. J. Infect. Dis. 157:1988;421-426.
16. Wullt B., Bergsten G., Samuelsson M., Svanborg C. The role of P fimbriae for Escherichia coli establishment and mucosal inflammation in the human urinary tract. Int. J. Antimicrob. Agents. 19:2002;522-538.
17. Johnson J.R. Virulence factors in Escherichia coli urinary tract infection. Clin. Microbiol. Rev. 4:1991;80-128.
18. Sandberg T., Kaijser B., Lidin-Janson G., et al. Virulence of Escherichia coli in relation to host factors in women with symptomatic urinary tract infection. J. Clin. Microbiol. 26:1988;1471-1476.
19. Barnes R.C., Daifuku R., Roddy R.E., Stamm W.E. Urinary-tract infection in sexually active homosexual men. Lancet. 1:1986;171-173.
20. Spach D.H., Stapleton A.E., Stamm W.E. Lack of circumcision increases the risk of urinary tract infection in young men. J. Am. Med. Assoc. 267:1992;679-681.
21. Ulleryd P., Lincoln K., Scheutz F., Sandberg T. Virulence characteristics of Escherichia coli in relation to host response in men with symptomatic urinary tract infection. Clin. Infect. Dis. 18:1994;579-584.
22. Andreu A., Stapleton A.E., Fennell C., et al. Urovirulence determinants in Escherichia coli strains causing prostatitis. J. Infect. Dis. 176:1997;464-469.
23. Terai A., Yamamoto S., Mitsumori K., et al. Escherichia coli virulence factors and serotypes in acute bacterial prostatitis. Int. J. Urol. 4:1997;289-294.
24. Ruiz J., Simon K., Horcajada J.P., et al. Differences in virulence factors among clinical isolates of Escherichia coli causing cystitis and pyelonephritis in women and prostatitis in men. J. Clin. Microbiol. 40:2002;4445-4449.
25. Rippere-Lampe K.E., Lang M., Ceri H., Olson M., Lockman H.A., O'Brien A.D. Cytotoxic necrotizing factor Type 1-positive Escherichia coli causes increased inflammation and tissue damage to the prostate in a rat prostatitis model. Infect. Immun. 69:2001;6515-6519.
26. Johnson D.E., Drachenberg C., Lockatell C.V., Island M.D., Warren J.W., Donnenberg M.S. The role of cytotoxic necrotizing factor-1 in colonization and tissue injury in a murine model of urinary tract infection. FEMS Immunol. Med. Microbiol. 28:2000;37-41.
27. Meares E.M., Stamey T.A. Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest. Urol. 5:1968;492-518.
28. Eykyn S., Bultitude M.I., Mayo M.E., Lloyd-Davies R.W. Prostatic calculi as a source of recurrent bacteriuria in the male. Br. J. Urol. 46:1974;527-532.
29. Smith J.W., Jones S.R., Reed W.P., Tice A.D., Deupree R.H., Kaijser B. Recurrent urinary tract infections in men. Ann. Intern. Med. 91:1979;544-548.
30. Blacklock N.J. The anatomy of the prostate: relationship with prostatic infection. Infection. 19:(Suppl 3):1991;S111-S114.
31. Ulleryd P., Zackrisson B., Aus G., Bergdahl S., Hugosson J., Sandberg T. Prostatic involvement in men with febrile urinary tract infection as measured by serum prostate-specific antigen and transrectal ultrasonography. BJU Int. 84:1999;470-474.
32. Zackrisson B., Hugosson J., Aus G. Transrectal ultrasound anatomy of the prostate and seminal vesicles in healthy men. Scand. J. Urol. Nephrol. 34:2000;175-180.
33. Griffiths G.J., Crooks A.J., Roberts E.E., et al. Ultrasonic appearances associated with prostatic inflammation: a preliminary study. Clin. Radiol. 35:1984;343-345.
34. Dalton D.L. Elevated serum prostate-specific antigen due to acute bacterial prostatitis. Urology. 33:1989;465.
35. Neal D.E., Clejan S., Sarma D., Moon T.D. Prostate specific antigen and prostatitis I. Effect of prostatitis on serum PSA in the human and non-human primate. Prostate. 20:1992;105-111.
36. Moon T.D., Clejan S., Neal D.J. Prostate specific antigen and prostatitis. II. PSA production and release kinetics in vitro. Prostate. 20:1992;113-116.
37. Horcajada J.P., Vilana R., Moreno-Martinez A., et al. Transrectal prostatic ultrasonography in acute bacterial prostatitis: findings and clinical implications. Scand. J. Infect. Dis. 35:2003;114-120.
38. Ronald A.R. Current concepts in the management of urinary tract infections in adults. Med. Clin. N. Am. 68:1984;335-349.
39. Schaeffer A.J. Urinary tract infection in men-state of the art. Infection. 22:(Suppl 1):1994;19-21.
40. Nicolle L.E. A practical guide to antimicrobial management of complicated urinary tract infection. Drugs Aging. 18:2001;243-254.
41. Booth C.M., Whiteside C.G., Milroy E.J.G., Turner-Warwick R.T. Unheralded urinary tract infection in the male. A clinical and urodynamic assessment. Br. J. Urol. 53:1981;270-273.
42. Lipsky B.A. Prostatitis and urinary tract infection in men: what's new; what's true? Am. J. Med. 106:1999;327-334.
43. Andrews S.J., Brooks P.T., Hanbury D.C., et al. Ultrasonography and abdominal radiography versus intravenous urography in investigation of urinary tract infection in men: prospective incident cohort study. Brit. Med. J. 324:2002;454-456.
44. Freeman R.B., Smith W.M., Richardson J.A., et al. Long-term therapy for chronic bacteriuria in men. US Public Health Service cooperative study. Ann. Intern. Med. 83:1975;133-147.
45. Gleckman R., Crowley M., Natsios G.A. Therapy of recurrent invasive urinary-tract infections of men. N. Engl. J. Med. 301:1979;878-880.
46. Sabbaj J., Hoagland V.L., Cook T. Norfloxacin versus co-trimoxazole in the treatment of recurring urinary tract infections in men. Scand. J. Infect. Dis. 48:(Suppl):1986;48-53.
47. Naber K.G. Urinary tract infection in men, including prostatitis, epididymitis, non-specific urethritis and Reiter's syndrome. Curr. Opin. Infect. Dis. 7:1994;9-19.
48. Bjerklund Johansen T.E., Grüneberg R.N., Guibert J., et al. The role of antibiotics in the treatment of chronic prostatitis: a consensus statement. Eur. Urol. 34:1998;457-466.
49. Sandberg T., Englund G., Lincoln K., Nilsson L.G. Randomised double-blind study of norfloxacin and cefadroxil in the treatment of acute pyelonephritis. Eur. J. Clin. Microbiol. Infect. Dis. 9:1990;317-323.
50. Cronberg S., Banke S., Bergman B., et al. Fewer bacterial relapses after oral treatment with norfloxacin than with ceftibuten in acute pyelonephritis initially treated with intravenous cefuroxime. Scand. J. Infect. Dis. 33:2001;339-343.
51. Ulleryd P., Sandberg T. Ciprofloxacin for 2 or 4 weeks in the treatment of febrile urinary tract infection in men: a randomized trial with a 1 year follow-up. Scand. J. Infect. Dis. 35:2003;34-39.
52. Rubin R.H., Shapiro E.D., Andriole V.T., Davis R.J., Stamm W.E. Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration. Clin. Infect. Dis. 15:(Suppl 1):1992;216-227.
53. Naber K.G., Busch W., Focht J. Ciprofloxacin in the treatment of chronic bacterial prostatitis: a prospective, non-comparative multicentre clinical trial with long-term follow-up. The German Prostatitis Study Group. Int. J. Antimicrob. Agents. 14:2000;143-149.
54. Sandberg T., Stokland E., Brolin I., Lidin-Janson G., Svanborg-Edén C. Selective use of excretory urography in women with acute pyelonephritis. J. Urol. 141:1989;1290-1294.
55. Johnson J.R. papG alleles among Escherichia coli strains causing urosepsis: associations with other bacterial characteristics and host compromise. Infect. Immun. 66:1998;4568-4571.
56. Otto G., Magnusson M., Svensson M., Braconier J., Svanborg C. pap genotype and P fimbrial expression in Escherichia coli causing bacteremic and nonbacteremic febrile urinary tract infection. Clin. Infect. Dis. 32:2001;1523-1531.